Fred E. Cohen - Insider Trading & Ownership

Entity
Individual
Location
301 Commerce Street, Suite 3300, Fort Worth, TX
Summary
The estimated net worth of Fred E. Cohen is at least $4.65M dollars as of August 8, 2024. Fred E. Cohen is the Director of CareDx, Inc. and owns shares of CareDx, Inc. (CDNA) stock worth about $2.29M. Fred E. Cohen is the Director of Intellia Therapeutics, Inc. and owns shares of Intellia Therapeutics, Inc. (NTLA) stock worth about $1.63M. Fred E. Cohen is the Director of Progyny, Inc. and owns shares of Progyny, Inc. (PGNY) stock worth about $725K.
All Insider Reports
All Insider Reports

Ownership of Fred E. Cohen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CDNA CareDx, Inc. Director $2.29M Jun 14, 2024
NTLA Intellia Therapeutics, Inc. Director $1.63M Jun 12, 2024
PGNY Progyny, Inc. Director $725K May 23, 2024
KYTX Kyverna Therapeutics, Inc. Director, 10%+ Owner Feb 12, 2024
URGN UroGen Pharma Ltd. Director Aug 6, 2024

Insider Transactions Reported by Fred E. Cohen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.